| 000 | 01801 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516144553.0 | ||
| 264 | 0 | _c20131211 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0b013e318290d9e1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Kyung-Sang | |
| 245 | 0 | 0 |
_aPharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cJul 2013 |
||
| 300 |
_a72-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPrasugrel Hydrochloride |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xdrug effects |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPark, Kyung Woo | |
| 700 | 1 | _aKelly, Ronan P | |
| 700 | 1 | _aGu, Namyi | |
| 700 | 1 | _aPayne, Christopher | |
| 700 | 1 | _aSmall, David S | |
| 700 | 1 | _aChoi, Hyunah C | |
| 700 | 1 | _aKawakatsu, Eiji | |
| 700 | 1 | _aPinton, Philippe | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 62 _gno. 1 _gp. 72-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0b013e318290d9e1 _zAvailable from publisher's website |
| 999 |
_c22677873 _d22677873 |
||